American Cryostem Revenue Growth Rates (CRYO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
American Cryostem Corporation  (CRYO)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

CRYO's Revenue Growth by Quarter and Year

American Cryostem's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRYO Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter September -
3rd Quarter June 0.04
2nd Quarter March 0.03
1st Quarter December 0.06
FY 0.13

CRYOs Annual Revenue
American Cryostem's Revenue in the fiscal year 2021 $ 0.02 millions
American Cryostem's Revenue in the fiscal year 2020 $ 0.56 millions
American Cryostem's Revenue in the fiscal year 2019 $ 0.32 millions
American Cryostem's Revenue in the fiscal year 2018 $ 1.10 millions
American Cryostem's Revenue in the fiscal year 2017 $ 1.87 millions




CRYO Revenue third quarter 2022 Y/Y Growth Comment
American Cryostem Corporation reported drop in Revenue in the third quarter 2022 by -67.23% to $ 0.04 millions, from the same quarter in 2021.
The fall in the third quarter 2022 American Cryostem Corporation's Revenue compares unfavorably to the Company's average Revenue doubling of 210.87%.

Looking into third quarter 2022 results within Healthcare Facilities industry 46 other companies have achieved higher Revenue growth. While American Cryostem Corporation' s Revenue meltdown of -67.23% ranks overall at the positon no. 3953 in the third quarter 2022.


CRYO Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter September - - -13.33 % 0 %
3rd Quarter June -67.23 % -7.14 % 1300 % -94.44 %
2nd Quarter March -76.92 % -18.75 % 300 % -83.33 %
1st Quarter December -53.85 % 0 % 8.33 % -77.78 %
FY   - -96.43 % 75 % -

Financial Statements
American Cryostem's third quarter 2022 Revenue $ 0.04 millions CRYO's Income Statement
American Cryostem's third quarter 2021 Revenue $ 0.13 millions Quarterly CRYO's Income Statement


CRYO Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter September - - -7.14 % 1400 %
3rd Quarter June 42 % 0 % -12.5 % -75 %
2nd Quarter March -50 % 0 % 23.08 % -66.67 %
1st Quarter December - 0 % -13.33 % -20 %
FY (Year on Year)   - -96.43 % 75 % -


Back to CRYO Growth rate Comparisons >> Back to CRYO Growth rate Comparisons >>


Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #47
Healthcare Sector #615
Overall #3953

Revenue Y/Y Growth Statistics
High Average Low
1206.05 % 210.87 % -100 %
(March 31, 2015)   (Sep 30 2021)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #47
Healthcare Sector #615
Overall #3953
Revenue Y/Y Growth Statistics
High Average Low
1206.05 % 210.87 % -100 %
(March 31, 2015)   (Sep 30 2021)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

American Cryostem's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1463.78 % 107.76 % -100 %
(Sep 30 2012)  


CRYO's III. Quarter Q/Q Revenue Comment
American Cryostem Corporation achieved in the III. Quarter 2022 below company average Revenue jump of 42% quarter on quarter, to $ 0.04 millions.

III. Quarter 2022 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0% in the III. Quarter a year ago.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While American Cryostem's Revenue growth quarter on quarter, overall rank is 584.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #125
Overall #584
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #125
Overall #584
Revenue Q/Q Growth Statistics
High Average Low
1463.78 % 107.76 % -100 %
(Sep 30 2012)  


CRYO's III. Quarter Q/Q Revenue Comment
American Cryostem Corporation achieved in the III. Quarter 2022 below company average Revenue jump of 42% quarter on quarter, to $ 0.04 millions.

III. Quarter 2022 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 0% in the III. Quarter a year ago.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While American Cryostem's Revenue growth quarter on quarter, overall rank is 584.


American Cryostem's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)
Cumulative Revenue 12 Months Ending $ -0.24 $ -0.15 $ -0.05 $ 0.01 $ 0.51
Y / Y Revenue Growth (TTM) - - - -97.86 % -12.67 %
Year on Year Revenue Growth Overall Ranking # 1918 # 0 # 0 # 3572 # 1089
Seqeuential Revenue Change (TTM) - - - -97.65 % -1.67 %
Seq. Revenue Growth (TTM) Overall Ranking # 3114 # 0 # 0 # 3794 # 987


Cumulative Revenue growth Comment
American Cryostem Corporation realized trailing twelve months of $ 0 millions, in the Jun 30 2022, compare to Revenue of $ 1 millions a year ago.

In the Healthcare sector 269 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1918.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 270
Overall # 1918

Revenue TTM Y/Y Growth Statistics
High Average Low
885.34 %
 90.71 %
-145.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 428
S&P 500 # 3114
Cumulative Revenue growth Comment
American Cryostem Corporation realized trailing twelve months of $ 0 millions, in the Jun 30 2022, compare to Revenue of $ 1 millions a year ago.

In the Healthcare sector 269 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 1918.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 270
Overall # 1918

Revenue TTM Y/Y Growth Statistics
High Average Low
885.34 %
90.71 %
-145.59 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 428
S&P 500 # 3114




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CRYO's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2022
Edwards Lifesciences Corporation-0.15%$ -0.153 millions
Chemed Corporation-0.18%$ -0.182 millions
Heska Corporation-0.39%$ -0.387 millions
Ati Physical Therapy Inc -0.45%$ -0.451 millions
Phenomex Inc -0.52%$ -0.519 millions
Organon and Co -0.63%$ -0.627 millions
Outset Medical Inc -0.63%$ -0.631 millions
Accuray Incorporated-0.82%$ -0.823 millions
Travere Therapeutics Inc -0.82%$ -0.824 millions
Elite Pharmaceuticals Inc -0.84%$ -0.835 millions
Amedisys Inc-1.11%$ -1.112 millions
Teleflex Incorporated-1.25%$ -1.252 millions
Embecta Corp -1.32%$ -1.322 millions
Y mabs Therapeutics inc -1.41%$ -1.406 millions
Organogenesis Holdings Inc -1.46%$ -1.457 millions
10x Genomics Inc -1.67%$ -1.672 millions
Mimedx Group Inc -1.88%$ -1.881 millions
Acorda Therapeutics Inc -2.31%$ -2.309 millions
Community Health Systems Inc -2.43%$ -2.428 millions
Alpha Pro Tech Ltd -2.43%$ -2.432 millions
Advanced Container Technologies Inc -2.54%$ -2.539 millions
Kamada Ltd -2.68%$ -2.678 millions
Fresenius Medical Care Ag-2.73%$ -2.730 millions
Orthofix Medical Inc -2.74%$ -2.738 millions
3m Company-2.77%$ -2.771 millions
Teva Pharmaceutical Industries Limited-3.17%$ -3.171 millions
Neurometrix Inc -3.40%$ -3.397 millions
Royalty Pharma Plc-3.43%$ -3.425 millions
Bio rad Laboratories Inc -3.47%$ -3.468 millions
Healthlynked Corp-3.63%$ -3.630 millions


About American Cryostem Revenue Growth Rates (CRYO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: American Cryostem Corp (CIK 1468679).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001019056-22-000573
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: American Cryostem Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.